coin-img-ETHETH+0.11%coin-img-SOLSOL-2.81%coin-img-BTCBTC-0.58%coin-img-XRPXRP-1.52%coin-img-ONDOONDO-13.33%coin-img-ZECZEC-12.43%coin-img-PSRMMPSRMM+0.00%coin-img-USDCUSDC+0.03%coin-img-ETHETH+0.11%coin-img-SOLSOL-2.81%coin-img-BTCBTC-0.58%coin-img-XRPXRP-1.52%coin-img-ONDOONDO-13.33%coin-img-ZECZEC-12.43%coin-img-PSRMMPSRMM+0.00%coin-img-USDCUSDC+0.03%coin-img-ETHETH+0.11%coin-img-SOLSOL-2.81%coin-img-BTCBTC-0.58%coin-img-XRPXRP-1.52%coin-img-ONDOONDO-13.33%coin-img-ZECZEC-12.43%coin-img-PSRMMPSRMM+0.00%coin-img-USDCUSDC+0.03%coin-img-ETHETH+0.11%coin-img-SOLSOL-2.81%coin-img-BTCBTC-0.58%coin-img-XRPXRP-1.52%coin-img-ONDOONDO-13.33%coin-img-ZECZEC-12.43%coin-img-PSRMMPSRMM+0.00%coin-img-USDCUSDC+0.03%
user-avatar
The Motley Fool Australia

CSL guides for about 5% underlying profit growth in FY2027 and announces a $1.1 billion buyback

AI Market Summary
CSL's FY2027 guidance for ~5% underlying profit growth beat expectations, alongside a US$1.1bn buyback and improving immunoglobulin sales momentum, reinforcing a recovery narrative after prior underperformance. The newsletter also highlights supportive backdrops for BHP via tight copper supply and for Woodside via elevated energy prices, but CSL is the most directly news-driven catalyst among the names cited.
Impact level
● Medium
Affected assets
NCSKCSCL2USD/USDT+0.81%
AI Insight · NCSKCSCL2USD/USDTAI Insight
▲ Bullish
Trade now
⚠️ AI-generated insights are based on news content and are provided for informational purposes only. They do not constitute investment advice or represent the views of BingX. Investing involves risk. Please trade responsibly.
Australian plasma products maker CSL issued FY2027 guidance, forecasting underlying profit growth of about 5% and topping market expectations. The company also announced a further $1.1 billion share buyback. CSL said immunoglobulin sales improved in the second half of FY2026. The stock has nearly doubled since early June, with investors watching whether it can move back above A$300.
Disclaimer: The content above is only the author's opinion and does not represent BingX’s stance. It shall not be construed as investment advice from BingX. For details, refer to the Terms and Conditions.
Stocks

Risk Warning

Cryptocurrencies and their derivatives are innovative financial products with great volatility and high investment risks.

Although BingX is committed to providing users with easy-to-use trading tools, trading itself is still a highly sophisticated field. Trading digital assets and their derivatives are subject to high market risk and price volatility and may result in partial or total loss of account funds. You must carefully consider and exercise clear judgment to evaluate your financial situation and the aforementioned risks before using BingX Services. You shall be responsible for all losses arising therefrom. If necessary, please consult relevant professionals to make informed decisions before investing. By accessing, downloading, using or clicking on "I agree" to accept any BingX Services provided by BingX, you agree that you have read, understood and accepted all of the terms and conditions stipulated in BingX Terms of Use as well as our Privacy Policy.


Trading by copying or replicating the trades of other traders involves a high level of risks, even when copying or replicating the top-performing traders. Past performance of a BingX community member is not a reliable indicator of his future performance. Content on BingX's trading platform is generated by members of its community and does not contain advice or recommendations by or on behalf of BingX.